APLIF (Appili Therapeutics) Long-Term Debt: $0.53 Mil (As of Dec. 2025)


What is Appili Therapeutics Long-Term Debt?

Appili Therapeutics APLIF +9.45% Long-Term Debt is $0.53 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Appili Therapeutics's Long-Term Debt for the quarter that ended in Dec. 2025 was $0.53 Mil.

Appili Therapeutics's quarterly Long-Term Debt declined from Jun. 2025 ($0.51 Mil) to Sep. 2025 ($0.44 Mil) but then increased from Sep. 2025 ($0.44 Mil) to Dec. 2025 ($0.53 Mil).

Appili Therapeutics's annual Long-Term Debt declined from Mar. 2023 ($5.52 Mil) to Mar. 2024 ($0.65 Mil) and declined from Mar. 2024 ($0.65 Mil) to Mar. 2025 ($0.51 Mil).

Appili Therapeutics  (OTCPK:APLIF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Appili Therapeutics Long-Term Debt Related Terms

Appili Therapeutics Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Appili Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Appili Therapeutics Long-Term Debt Chart

Appili Therapeutics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Long-Term Debt
Get a 7-Day Free Trial 0.75 3.86 5.52 0.65 0.51

Appili Therapeutics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.51 0.51 0.44 0.53
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.53 Mil mean?
Appili Therapeutics (APLIF) has a Long-Term Debt of $0.53 Mil as of Dec. 2025.
Is Appili Therapeutics' Long-Term Debt too high?
Appili Therapeutics' current Long-Term Debt is $0.53 Mil.
How does Appili Therapeutics' Long-Term Debt compare to VRTX and REGN?
Appili Therapeutics' Long-Term Debt of $0.53 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Appili Therapeutics's current Long-Term Debt is $0.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Appili Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Appili Therapeutics (APLIF) is currently considered Fairly Valued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 10% above its estimated fair value. The current Long-Term Debt is $0.53 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Appili Therapeutics (APLIF), the current Long-Term Debt is $0.53 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Appili Therapeutics Business Description

Other Exchanges APLI:Canada
Address 1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.